Update 10
Neuromodulation for COVID-19 update 10: Major steps forward
Published on: August 7, 2023

Update 9
Neuromodulation for COVID-19 update 9: More encouraging studies
Published on: May 8, 2023

Update 8
Neuromodulation for COVID-19 update 8: Encouraging news
Published on: February 14, 2023

Update 7
Neuromodulation for COVID-19 update 7: Electronic noses, NIH “RECOVER” recruits’ patients, New prospects.
Published on: August 5, 2022

Update 6
Neuromodulation for COVID-19 update 6: Breakthrough studies show efficacy pathways
Published on: May 20, 2022

Update 5
Neuromodulation for COVID-19 update 5: Increased urgency to developed neuromodulation treatments, ongoing taVNS results
Published on: February 25, 2022

Update 4
Neuromodec update 4: More evidence for Long-Covid and taVNS for Depressive Symptoms
Published on: January 5, 2022

Update 3
Neuromodulation for COVID-19 update 3: Open trials for Long-Covid
Published on: November 28, 2021

Update 2
NYU Langone launches an entirely home-based telemedicine neuromodulation treatment for a range of neurological disorders including Long-Covid. This treatment is based around transcranial Direct Current Stimulation. You can learn more and access treatment here.
Published on: May 30th, 2021

Update 1
Medical University of South Caroline and Soterix Medical announce a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety. Mark George, a leader in neuromodulation and co-leader of the trial says “When your body tries to fight off COVID… an inflammatory cascade that can kick in… A lot of people feel that the inflammation is what’s causing those symptoms to occur post-COVID. If we can reduce inflammation [with taVNS neuromodulation], we have a chance of reducing that.” Learn more and sign up here
Published on: November 16, 2020